| Breast (n=18) vs. gynecologic (n=14); % breast |
56% |
| Time Since Initial Diagnosis, years |
10.07 (7.15) |
|
Range (1-31) |
| Disease Free Interval, years |
5.21 (5.62) |
|
Range (.5-26) |
| Time since first recurrence, years, breast |
6.81 (6.02) |
| Time since first recurrence, years, gynecologic |
2.36 (1.88) |
| Current extent of disease |
|
| None; No evidence of disease (n=6) |
19% |
| Local or regional metastases (n=9) |
28% |
| Distant metastases (n=17) |
53% |
| Current cancer treatment |
|
| None (n=7) |
22% |
| Chemotherapy (n=22) |
69% |
| Hormonal therapy (n=7) |
22% |
